Lee Won Jin, Hoppin Jane A, Blair Aaron, Lubin Jay H, Dosemeci Mustafa, Sandler Dale P, Alavanja Michael C R
Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA.
Am J Epidemiol. 2004 Feb 15;159(4):373-80. doi: 10.1093/aje/kwh040.
The authors evaluated the incidence of cancer among pesticide applicators with exposure to alachlor in the Agricultural Health Study, a prospective cohort study of licensed pesticide applicators in Iowa and North Carolina. A total of 49,980 pesticide applicators are included in this analysis; 26,510 applicators (53%) reported use of alachlor on the enrollment questionnaire. Detailed pesticide exposure and other information were obtained from a self-administered questionnaire completed at the time of enrollment (1993-1997). Poisson regression analysis was used to evaluate the exposure-response relations between alachlor and cancer incidence controlled for the effects of potential confounding factors. A total of 1,466 incident malignant neoplasms were diagnosed during the study period, 1993-2000. Among alachlor-exposed applicators, the authors found a significant increasing trend for incidence of all lymphohematopoietic cancers associated with lifetime exposure-days (p for trend = 0.02) and intensity-weighted exposure-days (p for trend = 0.03) to alachlor. The risks of leukemia (rate ratio = 2.83, 95% confidence interval: 0.74, 10.9) and multiple myeloma (rate ratio = 5.66, 95% confidence interval: 0.70, 45.7) were increased among applicators in the highest alachlor exposure category. Our findings suggest a possible association between alachlor application and incidence of lymphohematopoietic cancers among applicators in the Agricultural Health Study.
在农业健康研究中,作者评估了接触甲草胺的农药施用者的癌症发病率。该研究是对爱荷华州和北卡罗来纳州持牌农药施用者进行的一项前瞻性队列研究。本分析共纳入49980名农药施用者;26510名施用者(53%)在入组问卷中报告使用过甲草胺。详细的农药接触情况和其他信息来自入组时(1993 - 1997年)自行填写的问卷。采用泊松回归分析来评估甲草胺与癌症发病率之间的暴露 - 反应关系,并对潜在混杂因素的影响进行控制。在1993 - 2000年的研究期间,共诊断出1466例新发恶性肿瘤。在接触甲草胺的施用者中,作者发现与甲草胺终身暴露天数(趋势p值 = 0.02)和强度加权暴露天数(趋势p值 = 0.03)相关的所有淋巴造血系统癌症的发病率呈显著上升趋势。在甲草胺暴露最高类别中的施用者中,白血病(率比 = 2.83,95%置信区间:0.74,10.9)和多发性骨髓瘤(率比 = 5.66,95%置信区间:0.70,45.7)的风险增加。我们的研究结果表明,在农业健康研究中,甲草胺施用与施用者淋巴造血系统癌症的发病率之间可能存在关联。